These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study. Paulsen JS; Long JD; Ross CA; Harrington DL; Erwin CJ; Williams JK; Westervelt HJ; Johnson HJ; Aylward EH; Zhang Y; Bockholt HJ; Barker RA; Lancet Neurol; 2014 Dec; 13(12):1193-201. PubMed ID: 25453459 [TBL] [Abstract][Full Text] [Related]
3. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Louis ED; Anderson KE; Moskowitz C; Thorne DZ; Marder K Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900 [TBL] [Abstract][Full Text] [Related]
4. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR; Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844 [TBL] [Abstract][Full Text] [Related]
5. Informativeness of Early Huntington Disease Signs about Gene Status. Oster E; Eberly SW; Dorsey ER; Kayson-Rubin E; Oakes D; Shoulson I J Huntingtons Dis; 2015; 4(3):271-7. PubMed ID: 26444024 [TBL] [Abstract][Full Text] [Related]
6. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165 [TBL] [Abstract][Full Text] [Related]
7. How different aspects of motor dysfunction influence day-to-day function in huntington's disease. Carlozzi NE; Schilling SG; Boileau NR; Chou KL; Perlmutter JS; Frank S; McCormack MK; Stout JC; Paulsen JS; Lai JS; Dayalu P Mov Disord; 2019 Dec; 34(12):1910-1914. PubMed ID: 31609508 [TBL] [Abstract][Full Text] [Related]
8. Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease. Gaura V; Lavisse S; Payoux P; Goldman S; Verny C; Krystkowiak P; Damier P; Supiot F; Bachoud-Levi AC; Remy P JAMA Neurol; 2017 Sep; 74(9):1088-1096. PubMed ID: 28672395 [TBL] [Abstract][Full Text] [Related]
9. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease. Maroof DA; Gross AL; Brandt J J Clin Exp Neuropsychol; 2011 Oct; 33(8):901-9. PubMed ID: 21644140 [TBL] [Abstract][Full Text] [Related]
10. Complex movement behaviour and progression of Huntington's disease. Andrich J; Saft C; Ostholt N; Müller T Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683 [TBL] [Abstract][Full Text] [Related]
11. Parkinsonism in Huntington's disease. Reilmann R Int Rev Neurobiol; 2019; 149():299-306. PubMed ID: 31779817 [TBL] [Abstract][Full Text] [Related]
12. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818 [TBL] [Abstract][Full Text] [Related]
13. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease. Aziz NA; Anguelova GV; Marinus J; van Dijk JG; Roos RA Eur J Neurol; 2010 Aug; 17(8):1068-74. PubMed ID: 20192977 [TBL] [Abstract][Full Text] [Related]
14. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis. Nagel M; Rumpf HJ; Kasten M Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988 [TBL] [Abstract][Full Text] [Related]
15. A clinical study of patients with genetically confirmed Huntington's disease from India. Murgod UA; Saleem Q; Anand A; Brahmachari SK; Jain S; Muthane UB J Neurol Sci; 2001 Sep; 190(1-2):73-8. PubMed ID: 11574110 [TBL] [Abstract][Full Text] [Related]
16. Preparing for preventive clinical trials: the Predict-HD study. Paulsen JS; Hayden M; Stout JC; Langbehn DR; Aylward E; Ross CA; Guttman M; Nance M; Kieburtz K; Oakes D; Shoulson I; Kayson E; Johnson S; Penziner E; Arch Neurol; 2006 Jun; 63(6):883-90. PubMed ID: 16769871 [TBL] [Abstract][Full Text] [Related]
17. Clinical markers of early disease in persons near onset of Huntington's disease. Paulsen JS; Zhao H; Stout JC; Brinkman RR; Guttman M; Ross CA; Como P; Manning C; Hayden MR; Shoulson I; Neurology; 2001 Aug; 57(4):658-62. PubMed ID: 11524475 [TBL] [Abstract][Full Text] [Related]
18. Critical periods of suicide risk in Huntington's disease. Paulsen JS; Hoth KF; Nehl C; Stierman L Am J Psychiatry; 2005 Apr; 162(4):725-31. PubMed ID: 15800145 [TBL] [Abstract][Full Text] [Related]
19. Predictors of nursing home placement in Huntington disease. Wheelock VL; Tempkin T; Marder K; Nance M; Myers RH; Zhao H; Kayson E; Orme C; Shoulson I; Neurology; 2003 Mar; 60(6):998-1001. PubMed ID: 12654967 [TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease. van Vugt JP; Siesling S; Piet KK; Zwinderman AH; Middelkoop HA; van Hilten JJ; Roos RA Mov Disord; 2001 May; 16(3):481-8. PubMed ID: 11391742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]